Estradiol, Progesterone

Bijuva

1 MG + 100 MG CapsuleCanadaMarketedAuthorised 31 Jan 2024

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Bijuva 1 MG/100 MG Capsulas BlandasSpain · 1 mg + 100 mg · cápsula blanda · Theramex Ireland LimitedSame brand
BijuvaItaly · Capsula molle · Theramex Ireland LimitedSame brand
Bijuva 1 mg/100 mg zachte capsulesNetherlands · Capsule, zacht · Theramex Ireland LimitedSame brand
BijuvaUnited States · 0.5MG; 100MG, 1MG; 100MG · capsule · Mayne PharmaSame brand
Estradiol and ProgesteroneUnited States · 1MG; 100MG · capsule · Amneal PharmsSame form

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Estradiol, Progesterone

Bijuva

1 MG + 100 MG CapsuleCanadaMarketedAuthorised 31 Jan 2024

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Estradiol, Progesterone
Strength: 1 MG + 100 MG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Jan 2024
Registration: DIN 02505223
Marketing authorisation holder: Knight Therapeutics INC.
ATC code: G03FA04
Group: Genito-urinary system and sex hormones
Supply: PRESCRIPTION